Abstract
Objectives Fat-infiltrated axillary lymph nodes (LNs) are unique sites for ectopic fat deposition. Early studies showed a strong correlation between fatty LNs and obesity-related diseases. Large-scale studies are needed to confirm these preliminary results but this is hampered by the scarcity of labeled data. With the long-term goal of developing a rapid and generalizable tool to aid data labeling, we developed an automated deep learning (DL)-based pipeline to classify the status of fatty LNs on screening mammograms.
Methods Our internal dataset included 886 mammograms from a tertiary academic medical institution, with a binary status of the fat-infiltrated LNs based on the size and morphology of the largest visible axillary LN. A two-stage DL model training and fine-tuning pipeline was developed to classify the fat-infiltrated LN status using the internal training and development dataset. The model was evaluated on a held-out internal test set and a subset of the Digital Database for Screening Mammography.
Results Our model achieved an accuracy of 0.97 (95% CI: 0.94-0.99) on 264 internal testing mammograms and an accuracy of 0.82 (95% CI: 0.77-0.86) on 70 external testing mammograms. The model successfully extracted meaningful LN-related features from the mammograms.
Conclusion This study confirmed the feasibility of using a DL model for fat-infiltrated LN classification. The model provides a practical tool to identify fatty LNs on mammograms and to allow for future large-scale studies to evaluate the role of fatty LNs as an imaging biomarker of obesity-associated pathologies.
Advances in knowledge Our study is the first to classify fatty LNs using an automated DL approach.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This research was supported in part by grants from the US National Institute of Health (R01CA249758, R01LM012837, P20GM104416).
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
This study, and the usage of human participant data in this project, were approved by the Dartmouth-Hitchcock Medical Center Institutional Review Board (IRB) with a waiver of informed consent.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
A de-identified version of the data and the source code for this analysis can be shared with interested researchers upon reasonable request.
